Abstract:To develop and characterize a new cancer target gene delivery carrier, which could be used as potential blood pool magnetic resonance (MR) contrast agents, a novel FAM-AGKGTPSLETTPC-COOH/poly(ether-amide) (FAM-13/PEG/DTPA) copolymer (III) with fluorescence probe was designed and obtained first from the reaction of the amino group terminated poly(ether-amide) (PEG/DTPA) copolymer ligand (II) with heterobifunctional cross-linker m-maleimidobenzoyl-N-hydroxysuccinimide ester (MBS) (Step 2), and then Michael addition of C = C double bond in MBS moiety with SH group in FAM-labeled hepatocarcinoma specific adhesin peptide, FAM-AGKGTPSLETTPC-(SH)-COOH (FAM-13), in high yield (Step 3). II was prepared by the reaction of diethylenetriamine pentaacetic acid dianhydrid (DTPAA) with amino group terminated PEG(I) (Step 1). The two copolymers of II and III were characterized by H-1-NMR and C-13-NMR measurements. The liver tumor-specific identification and antigen localization of III with the fluorescin-labeled FAM-13 peptide were performed under cellular level. Targeting properties of III were tested on the normal cells and liver cancer cells, respectively. No fluorescence was observed on normal liver cells L-02, while strong yellowish green fluorescence was observed on the liver cancer cells BEL-7404. The property of FAM-13 peptide in III for recognizing specifically the liver cancer cells was demonstrated. It was also demonstrated that the chemically synthesized III with peptide FAM-13 still had the property for targeting on the surface membrane of liver cancer cells in vitro, thus further indicating that the specific targeting effect of the objective tissue was mediated by the peptides of III insert into the cell membrane. It is evident that the III with FAM-13 peptide would be an excellent candidate for the targeting therapy to hepatocarcinoma. So ligand molecules III with targeting peptides can target hepatocellular carcinoma. Ligand III is a promising candidate, which can be coordinated with Gd3+, ion to give the macromolecular contrast agent.

A Novel Fluorescent Label Based on Organic Dye-Doped Silica Nanoparticles for HepG Liver Cancer Cell Recognition

Anti-CD155 and anti-CD112 monoclonal antibodies conjugated to a fluorescent mesoporous silica nanosensor encapsulating rhodamine 6G and fluorescein for sensitive detection of liver cancer cells.

Identification of Live Liver Cancer Cells in a Mixed Cell System Using Galactose-Conjugated Fluorescent Nanoparticles.

A Novel Fluorescent Label Based on Biological Fluorescent Nanoparticles and Its Application in Cell Recognition

A Fluorescent and Chemiluminescent Difunctional Mesoporous Silica Nanoparticle As a Label for the Ultrasensitive Detection of Cancer Cells.

Bio-molecule-conjugated fluorescent organically modified silica nanoparticles as optical probes for cancer cell imaging.

Synthesis and application of a targeting diagnosis system via quantum dots coated by amphiphilic polymer for the detection of liver cancer cells

Au@SiO2@CuInS2–ZnS/Anti-AFP Fluorescent Probe Improves HCC Cell Labeling

Specific Hepatocellular Carcinoma Imaging Based on Aggregation-Induced Emission Nanoparticles

Nanometer Fluorescent Hybrid Silica Particle As Ultrasensitive and Photostable Biological Labels

Novel fluorescent silica nanoparticle probe for ultrasensitive immunoassays

Functionalized Fluorescein-Doped Sio2 Nanoparticles for Immunochromatographic Assay

Immunofluorescence Detection with Quantum Dot Bioconjugates for Hepatoma in Vivo.

Immuno-fluorescence imaging of hepatocellular carcinoma cells with quantum dots

Highly Fluorescent Dye-Doped Silica Nanoparticles Increase Flow Cytometry Sensitivity for Cancer Cell Monitoring

Synthesis of Fluorescene Labeled Peptide/Poly(Ether-Amide) with Targeting Function to Liver Cancer Cells

Synthesis, Characterizations of Dye-Doped Silica Nanoparticles and Their Application in Labeling Cells.

Dual-Lanthanide-Chelated Silica Nanoparticles as Labels for Highly Sensitive Time-Resolved Fluorometry

Preparation of Novel Fluorescent Nanocomposites Based on Au Nanoclusters and Their Application in Targeted Detection of Cancer Cells.

Folic Acid-Functionalized Mesoporous Silica Nanospheres Hybridized with Aie Luminogens for Targeted Cancer Cell Imaging

Aqueous CdTe quantum dots for labeling liver cancer cells